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A one-step template-free synthesis of hollow ZnO microspheres has been developed by a hydrothermal route in the 
presence of (+)-catechin as crystal habit modifier. Morphology evolution of ZnO particles shows the transformation from 
hexagonal rods to microspheres with increase in the concentration of catechin in the reaction medium. The microspheres are 
formed by the aggregation of fine grained nano-sized ZnO particles. The synthesized particles show enhanced photocatalytic 
ability and high potency as a drug delivery agent. 
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Zinc oxide (ZnO), a group II-VI semiconductor 
having a direct bandgap of 3.37 eV has attracted 
significant attention in both industry and academia, 
owing to its wide number of applications
1-8
. ZnO has 
been used extensively in photocatalysis, solar cells, 
optical and sensor based applications
9-15
. It is the 
material of choice due to its limited solubility, low 
toxicity, good biocompatibility and low cost. For 
many of its applications, the size and morphology of 
ZnO crystals have been tuned via crystal habit 
modification. Myriad shapes ranging from sphere, 
tetra pods, spikes, pyramids, dumbbells and flowers 
are amongst the common structural aggregates 
obtained by crystal habit modification
16-23
. The 
possibility of facile synthesis in the nanoscale 
domain, in varying shapes like zero-dimensional 
nanodots, one-dimensional nanorods and two-
dimensional sheets that influence the bulk and surface 
properties of ZnO have renewed interest on this 
material
24-26
. However, being a semiconductor with a 
wide band gap at room temperature, ZnO has limited 
utilization of photonic energy, and thus, inferior 
photocatalytic efficacy compared to other materials 
like TiO2.  
Hierarchical structures and hollow particles are 
reported to boost the photo-physical and functional 
properties of ZnO, owing to optimal surface area, 
greater permeability and lower density compared to 
other morphologies
27-32
. Conventional processes 
involve templated synthesis, hydrothermal reactions 
and thermal evaporation techniques to synthesize such 
particles
33-36
. Synthesis of ZnO layers using hard 
templates such as carbon sphere, polystyrene beads 
and silica particles that can be easily eliminated from 
the reaction medium through dissolution or 
combustion is well reported in literature. In this 
process, both single shell and multi-shell structures 
have been successfully fabricated
37-40
. The other 
technique relies on using soft templates such as 
self-assemblies of macromolecules, surfactants and ionic 
liquids. Often, a combination of both these techniques is 
used for the synthesis of hollow sphere having precise 
control on surface and bulk properties
41, 42
. Though these 
methods allow control over particle size and shell 
thickness of hollow spherical ZnO, they are not 
operationally viable at a large scale, owing to multi-step 
processes that are cost-intensive. 
In recent times, there have been attempts to use 
template-free routes for synthesis. The mechanism 
of such synthesis involves a combination of 
Ostwald ripening and Kirkendall-type diffusion
43-46
. 
Ibrahim et al.47 used PVP and water/ ethanol mixture 
to obtain hollow spheres by maintaining a balance 
between the Ostwald ripening step and self-
transformation. Wang et al. combined the cumulative 
effect of citrate ion induced coordination of ZnO 
precursor and Kirkendall effect to produce uniform 
hollow ZnO spheres with enhanced photocatalytic 
properties
48
. By suitably controlling the temperature and 
time of solvothermal reaction, template-free hollow 
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spheres were obtained by Ihara et al.
49
 Thermal 
evaporation process was used for synthesis of hollow 
ZnO using metallic zinc at high temperature in a tube 
furnace
50
. Though these examples open up new 
approaches to achieve hollow particles, they lack the 
ease of synthesis, due to requirements of elevated 
temperature and costly experimental set-up. It was 
therefore pertinent to study the effect of crystal habit 
modifier under benign reaction conditions to obtain 
hollow particles. 
Crystal habit modification involves small organic 
molecules which can selectively bind to specific 
crystal faces, thus regulating the crystal growth 
in a particular direction. Small molecules having 
functional groups such as carboxylates, polyhydric 
alcohols and amino acids are typically used in 
such processes. Combinations of monohydric and 
polyhydric alcohols have been used to produce 
nanoparticle-assembled hollow spherical ZnO 
particles by facile solvothermal route
51
. Polyol 
induced self-assembly of nanoparticles resulting in 
generation of hollow spheres has been discussed by 
Kim et al.
52
 Recently, there has been emphasis on 
using benign polyphenolic molecules derived from 
extracts of common beverages like tea, coffee 
and wine, for modulation of ZnO morphology
53, 54
. 
Nanostructured ZnO particles were synthesized from 
extracts of both common beverages as well as some 
of the pure polyphenolic components viz., EGCG
55,56
. 
Like other commonly available flavonoids, catechin, 
which is abundantly present in green tea, red wine and 
as vegetable fluids is known to coordinate strongly with 
polyvalent metal ions in aqueous medium. The effect 
of such coordination with Zn
2+
 is also well reported in 
literature
57-59
. In alkaline medium, catechin and Zn
2+
 




In the current work, we have explored the 
coordinating effect of (+)-catechin on ZnO 
crystallization in presence of a weak hydrolyzing 
base, as a potential template-free route to synthesize 
hollow microspherical particles and have explored the 
feasibility of using it for multifunctional benefits such 
as controlled delivery of a drug, ampicillin and as a 
superior photocatalyst. 
Materials and Methods 
All chemicals were of analytical grade and used 
without further purification. Zinc nitrate hexahydrate 
(Zn(NO3)2.6H2O, AR grade), hexamethylenetetramine 
(HMTA, C6H12N4, AR grade) and (+)-catechin 
hydrate (C15H14O6, AR grade) were procured 
from Sigma-Aldrich. Distilled water used in all 
experimental processes had the following characteristics: 







dissolved salt < 0.5 mg/L and turbidity 
<0.1 NTU. 
Synthesis of ZnO particles 
ZnO particles were synthesized by following 
a conventional hydrothermal route using 
Zn(NO3)2.6H2O as the source of zinc ions and HMTA 
as slow hydrolyzing base at elevated temperature. 
Briefly, 50 mM of Zn(NO3)2.6H2O (1.49 g, 0.1 M) 
and 50 mM of HMTA (0.70 g, 0.1 M) were mixed at 
room temperature in sealed autoclave containers, 
stoppered and heated in an air oven for 3 h. For 
reactions where (+)-catechin was used as additive to 
affect crystal habit, requisite amount of additive was 
completely dissolved in the Zn(NO3)2.6H2O stock 
solution to obtain a clear solution. This solution was 
mixed with HMTA and the reaction was carried out 
for 3 h. On completion of the reaction, the reaction 
mixtures were cooled to room temperature and the 
particles were filtered through Whatman 40 filter 
paper. The precipitate was washed thoroughly with 
deionized water followed by copious amounts of 
ethanol and dried in air. For studying the kinetics of 
formation of ZnO, the reaction was quenched at 
different intervals of time and the particles formed 
were analyzed. The compositions of the different sets 
of reaction are given in Table 1. 
Characterization 
Powder X-ray diffraction (PXRD) pattern of the 
synthesized ZnO particles were taken using a Rigaku 
Ultima IV diffractometer using Cu-Kα (λ = 1.5406 Å) 
radiation with a step size of 0.1°/s and 2θ angle 
between 20° to 70°. Joint committee for powder 
diffraction standards (JCPDS, card number 36-1451) 
was used to assign XRD peak positions and relative 
intensities. Scanning electron microscope (SEM) was 
used to ascertain the morphological evolutions of 
the synthesized particles using a Hitachi S-4700 
machine at an accelerating voltage of 10 kV. Energy 
Table 1 — Compositions of reactant and habit modifier for 









ZnO-1 50 50 0.0 - 
ZnO-2 50 50 0.5 1:100 
ZnO-3 50 50 1.0  1:50 
ZnO-4 50 50 10   1:5 




dispersive X ray analysis (EDXA) was used to 
determine the elemental composition of the particles. 
High resolution transmission electron microscopy 
(HRTEM) was performed using JEOL-TEM 2100 
microscope with an operating voltage of 200 kV to 
image the crystallite shape and the lattice fringes. 
Room temperature Fourier transform infrared (FTIR) 
measurements were made on a Perkin-Elmer FTIR 
spectrophotometer (model Spectrum-1) with a 
resolution of 4 cm
-1
 using the KBr pellet technique. 
Pyris thermal analyzer (model Pyris-1 TGA) was used 
to determine decomposition components under a dry 
N2 flow from 25 °C to 700 °C at a heating rate of  
10 °C min
−1
. Calcination of the ZnO samples was 
done at 400 °C, 500 °C and 600 °C using a muffle 
furnace. The BET surface area was calculated using a 
BET surface analyzer (Smart Instruments) for  
the synthesized ZnO samples and average pore sizes 
were calculated.  
 
Photocatalytic activity 
Photocatalytic efficacy of the calcined ZnO 
powders was studied by following the degradation of 
methylene blue dye. The synthesized ZnO (5 mg) was 
added to 100 mL of 20 μM dye solution taken in a 
photocatalytic reactor. The suspension was then 
irradiated with UV light from a mercury lamp (60 W, 
365 nm) under constant stirring condition (400 rpm, 
25 °C). Aliquots were taken out from the reactor  
at every 5 minutes during irradiation, centrifuged  
and their absorbance were recorded at 664 nm 
(absorbance maxima of methylene blue in water) 
using a Perkin-Elmer Lambda-35 UV-vis spectro-
photometer. Blank dye degradation was also  
carried out under similar condition without adding  
the catalyst.  
The drug delivery of ampicillin antibiotic was 
studied by loading the drug on different ZnO 
particles. Ampicillin sodium salt (0.5 g) was dissolved 
in 100 mL deionized water. To this solution (25 mL), 
ZnO particles (50 mg) were added. The mixture was 
stirred using a magnetic stirrer for 2 h. The drug 
loaded particles were centrifuged at 5000 rpm for  
5 min and washed thoroughly with distilled water  
3 times. The resultant particles were dried under 
vacuum overnight. The drug loading on the particles 
was examined by TGA analysis prior to the drug 
release profile evaluation. To study the drug release 
profile, 50 mg of the drug loaded ZnO particles, were 
suspended in 50 mL of PBS buffer and agitated in a 
reciprocating shaker at 200 rpm. Aliquots were drawn 
out from the supernatant solution at specific intervals 
of time and passed through a 0.45 µm syringe filter. 
For every aliquot withdrawal, 3 mL of fresh PBS 
buffer was replenished in the solution to maintain 
constant volume. Spectrophotometric quantification 
of the drug released in solution was measured at 268 nm 
corresponding to the λmax of ampicillin molecule. 
 
Results and Discussion 
 
Synthesis of ZnO particles 
Synthesis of ZnO by hydrothermal route was 
carried out at 95 °C using zinc nitrate and 
hexamethylenetetramine (HMTA) as reactants. 
Typical reaction for the formation of ZnO proceeds 



















  ZnO + H2O … (4) 
 
The reaction involves generation of ammonia at an 
elevated temperature due to hydrolysis of HMTA in 
the first step. The second step involves the reaction of 
zinc salt with the alkaline ammonia solution to 
produce crystalline ZnO particles. It is well studied in 
literature that presence of ligands which easily 
associate with Zn
2+
 ions can lead to morphological 
diversities in the precipitated ZnO crystal due to their 
influence on the kinetics of crystallization and  
relative binding onto specific crystal planes
62
. Metal 
complexation with polyphenols such as quercetin, 
rutin and catechin has been extensively studied
59, 63-65
. 
Zinc is the first transition series element having 10 d 
electrons in its outermost shell, which lowers its 
ability to form a complex compared to other 
counterparts. However, it is still known to bind 
preferentially with hydroxyl groups in polyphenolic 
compounds resulting in the formation of stable  
zinc-polyphenol complexes
53-55
. (+)-Catechin being 
highly water soluble and one of the abundant natural 
polyphenol was chosen as a suitable modifier owing 
to its ability to bind with Zn
2+
 in aqueous medium, 
which in turn could affect the kinetics of  
nucleation and crystal growth of the ZnO particles. In 
the present study, extent of crystal habit modification 
was varied by adding various concentrations of  
(+)-catechin in the reaction medium in the beginning 
of the reaction. 
 
Morphology of ZnO: SEM and TEM studies 
It is evident from Fig. 1, that in the absence of  
any modifier, hexagonal rod-like ZnO particles with 




varied particle sizes were formed. However, in the 
presence of (+)-catechin, morphological diversities 
were observed and extent of variation increased  
with increase in the concentration of catechin  
in the reaction medium. At very low concentration  
of catechin (0.5 mM), tapering in the hexagonal  
rod morphology was observed which became  
more pronounced with increase in the concentration 
of modifier. 
Catechin is a polyphenol and thus presents 
possibilities of complexing with the Zn
2+
 ion through 
coordinate bonding where oxygen atom acts as the 
electron donor. It can be hypothesized that this 
interaction facilitates the prolongation of the 
nucleation step (reaction 4) in the formation of ZnO 
which in turn regulates the crystal growth
17
. 
Additionally, the catechin moiety is expected to have 
greater affinity to the (0001) plane of the ZnO crystal 
owing to the polar nature of the crystal and the 
relative abundance of Zn
2+
 ions in the lattice positions 
in this plane
17
. Such kind of binding may affect the 
final morphology of ZnO particles by making them 
more suppressed along the c axis. As is evident from 
our study, increase in the catechin content 
transformed the free forming hexagonal rod 
morphology to clusters of hexagonal disks eventually 
forming microspherical structures. It is worth 
mentioning that the microspherical structures formed 
in the presence of a significantly large concentration 
of catechin (10 mM) was found to have small 
openings and that it is formed by the aggregation of 
large number of fine grained ZnO nanoparticles. 
Pure and crystalline wurtzite ZnO phase with 
distinct lattice fringes having a d spacing of 0.26 nm 
corresponding to (002) crystal plane could be 
identified on the surface of the ZnO microspheres 
from TEM measurements (Fig. 2). The surface of the 
ZnO microspheres appear to be interspaced with a 
combination of nanocrystalline ZnO and a non-
descriptive phase, which may result due to the 
adsorbed catechin in the ZnO matrix or the 
subsequent complexation with Zn
2+
 ions. This leads 
us to the conjecture that the ZnO microspheres are 
formed by the aggregation of nanoparticulate ZnO 
with primary crystallite size of ~2.5–5 nm. This is 
further confirmed by the SEM study where we  
have visualized the ZnO microspheres formed by 
aggregation of ZnO nanocrystals. This assemblage is 
evidently influenced by a large amount of catechin in 
the reaction medium, which complexes extensively 
with the Zn
2+
 ions, thus subduing its rate of 
conversion to ZnO. Also, the catechin adsorbed on the 
surface of ZnO crystals may also regulate the 
evolution of this unique structure possibly by 
facilitating ‘cohesive fusion’ of the crystals at the 
initial stage of the reaction as shown in Fig. 3.  
Growth kinetics of the microspherical ZnO 
particles was studied by withdrawing small portions 
of the reaction volume and analyzing the nature of the 
particles formed at different intervals of time.  
The study was done for ZnO-4 sample, since it 
resulted in microspheres. It is evident from Fig. 4 that 
morphology evolution of ZnO proceeds through  
the formation of non-descriptive agglomeration of 
particles at the start of the reaction followed by the 
formation of nanospheres which eventually fuse and 
grow to larger microspherical assemblages. With 
increase in time of the reaction, the transformation of 
 
 
Fig. 1 — SEM images of ZnO particles synthesized in presence of varying amounts of (+)-catechin. [(a, b) 0; (c, d) 0.5; (e, f) 1.0;  
(g, h) 10 mM. [b, d, f, h are higher resolution SEM images of a, c, e, g respectively]. 
 




nanostructure to micro-structured spheres with 
adequate surface roughness was observed, which may 
be indicative of the adsorption of the carbon rich 
catechin moiety onto ZnO particles.  
The presence of high quantity of carbon arising 
from the catechin moiety in the matrix of spherical 
ZnO particles was further evidenced by EDX mapping 
(Supplementary Data, Fig S1). Subsequently, the 
synthesized spherical ZnO was calcined to remove the 
organic content. Post calcinations, the EDX spectra 
showed significant reduction in the carbon content in 
the calcined ZnO samples.  
Characterization 
X-ray crystallography of the samples were 
performed to elucidate the crystallinity of the material 
synthesized in the presence of (+)-catechin as  
crystal habit modifier. The comparative XRD plot of 
different samples is shown in Fig. 5. All samples 
showed the characteristic peaks of wurtzite form  
of ZnO (JCPDS no. 36-1451) and no peaks 
corresponding to intermediate compounds were 
observed. This clearly shows that pure phase ZnO 
with varied morphologies could be synthesized in the 
presence of catechin as modifier, and transient 
 
 




Fig. 3 — FESEM images of ZnO-4 microspheres synthesized in bulk at different magnifications. [Red circles in (a) indicate the holes on 
the spherical surface]. 
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complexation which may arise at the intermediate 
stage of the reaction does not remain in the ZnO 
matrix at the completion of the reaction. We also 
observed a consequent decrease in the X-ray 
diffraction intensity as the concentration of catechin 
increased in the reaction mixture, which essentially 
shows that substantial part of the catechin remains 
trapped in the ZnO matrix and that crystallization is 
possibly affected by the presence of catechin, thus 
promoting more amorphous type particles.  
To further investigate the presence of entrapped 
catechin in the ZnO particles, FTIR analysis of the 
synthesized samples were done. The comparative plot 
of catechin alone vis-à-vis ZnO particles synthesized 
in presence of catechin is presented in Fig. S2 
(Supplementary Data). It is evident from the FTIR 
spectra that prominent catechin peaks are observed 
in the spectra of the synthesized particles and the 
peak intensity increases with increase in the 
concentration of catechin in the ZnO matrix. The 
characteristic peaks corresponding to C-H alkenes 
(970 cm
-1







), C-H alkanes (1470 cm
-1
) and 
aromatic C=C stretching (1519 cm
-1
) were detected in 
pure catechin sample and signature peaks were 
also found in the ZnO composite particles synthesized 
in presence of catechin. Further, we observed 







 and 1607 cm
-1
 respectively in the 
ZnO samples. Also, the absence of 1030, 1143 and 
1470 cm
-1
 peaks in the ZnO samples were suggestive 
of possible chemical association of the catechin 
molecule to Zn
2+
 in addition to being adsorbed onto 
the surface.  
To corroborate the FTIR results, thermogravimetric 
analysis of the samples synthesized in presence of 
varying concentrations of catechin was performed. 
It is evident from Fig S3 (Supplementary Data), that 
incorporation of substantial amount of organic 
matter in the ZnO matrix takes place. Pure catechin 
undergoes several weight losses between 100 °C 
and 350 °C corresponding to the loss of -OH groups 
175–177 °C and consequent decomposition at higher 
temperatures. The characteristic decomposition 
weight losses between 275–350 °C were found in the 
synthesized ZnO samples, ascertaining that catechin is 
associated in the crystal matrix. The extent of 
catechin present in the ZnO matrix increased with the 
increase in concentration of catechin used during 
the synthesis.  
Fig. 4 — FESEM images depicting the growth kinetics of ZnO-4 microspheres after (a) 10, (b) 20, (c) 30, (d) 45, (e) 60, and, (f) 90 min of reaction. 
Fig. 5 — XRD profiles of synthesized ZnO particles. [(1) ZnO-1; 
(2) ZnO-2; (3) ZnO-3; (4) ZnO-4]. 





Photocatalytic studies were performed on calcined 
ZnO samples prepared by annealing the as-prepared 
samples at varied temperatures, in order to remove the 
adsorbed catechin and check the efficacy on the 
resultant calcined materials. The degradation of an 
anionic dye, methylene blue (MB) was monitored 
using calcined ZnO particles under UV light 
irradiation. For the study, ZnO-4 samples were 
calcined separately at 400 °C, 500 °C and 600 °C 
respectively and compared with calcined (600 °C) 
conventional hexagonal ZnO rods (ZnO-1) as shown 
in Fig. 6. MB dye is known to undergo degradation in 
the presence of UV light, which is enhanced 
considerably by the presence of ZnO catalyst. In the 
presence of ZnO-4, photodegradation of dye for all 
samples followed pseudo-first order kinetics with the 
rate of degradation in the following order:  
ZnOcal600° > ZnOcal500° > ZnOcal400° > ZnOconventional > MB. 
The calculated rate constants for dye degradation of the 
above samples were 0.0842, 0.0728, 0.0439, 0.0399 
and 0.017 min
-1 
respectively. The enhancement in the 
photocatalytic efficacy with increase in the 
calcination temperature may be attributed to the 
superior photosensitization of dye molecule by the 
ZnO particle as the calcination temperature is 
increased. It can be envisaged that higher calcination 
temperature aids in modulating ZnO microstructures 
by effectively removing the organic modifier.  
Also, with increase in calcination temperature there  
is a consequent increase in the crystallite size. 
Mechanistic interpretation of photocatalysis suggests 
that the generation of OH radicals during photooxidation 
process drives photo catalysis. We estimated the  
OH index of the materials to correlate with their 
photocatalytic efficiency. For this purpose,  
P25 titanium dioxide (obtained from Degussa) is 
taken as benchmark (indexed as 100) for calculating 
the OH index of other materials (Supplementary Data, 
Fig S4). The OH index of commercially available 
ZnO is reported in literature to be 16.4. In comparison, 
the OH index determined for calcined ZnO-4 at 600 ⁰C 
was found to be 86.8, thus showing significant 
improvement in the efficiency of photocatalysis by ZnO 
particles, which has been achieved by suitably 
controlling the crystal growth and the calcination 
temperature. No morphological changes of the ZnO 
particles were observed upon photocatalytic 
degradation of the dye on its surface. 
 
Efficacy of drug delivery  
To evaluate the potency of using the synthesized 
microspherical ZnO as a delivery vehicle for drugs, a 
study was done on a model drug, ampicillin. 
Ampicillin belongs to the group of beta-lactam 
antibiotics and is commonly used as a broad-spectrum 
antibiotic that can be administered therapeutically to 
control both gram-positive and gram-negative 
bacterial infections
69
. Ampicillin is (2S,5R,6R)-6-
([(2R)-2-amino-2-phenylacetyl]amino)-3,3-dimethyl-
7-oxo-4-thia-1-azabicyclo [3.2.0]heptane-2-carboxylic 
acid having the formula C16H19N3O4S. In recent times, 
several attempts have been made to develop efficient 
drug delivery agents, selected from both inorganic 
carriers and organic encapsulates to affect the delivery 
efficacy, sustained release and targeted dispensation 
of the drug molecules. Amongst the inorganic 
carriers, often insoluble benign particles selected from 
ZnO, CaCO3 and TiO2 have been used
70, 71
. ZnO has 
been extensively analyzed by the Food and Drug 
Administration in the United States and classified as a 
safe ingredient for therapeutic use
72
. It was also 
demonstrated that by increasing the surface-to-volume 
ratio of these compounds it is possible to improve the 
drug loading and sustained release profile of the 
composites. For this purpose, concerted efforts were 
undertaken to synthesize shape selective nanoparticles 
for optimal performance. Courrier et al.
73
 demonstrated 
that particle size of less than 50 nm is preferred since 
it can penetrate the cell barrier and thus deliver the 
drug at the source. However, being nanoparticles, 
they pose a serious threat of being cytotoxic if the 
dosage is not controlled appropriately. The challenge 
therefore lies in delivering the sustained release 
profile of the drug from a microparticulate composite. 
It is well reported in literature that the microstructure 
 
 
Fig. 6 — Photocatalytic degradation profile of MB dye. [(1) No ZnO; 
(2) ZnO-1 calcined at 600 °C; ZnO-4 calcined at (3) 400 °C,  
(4) at 500 °C, and, (5) at 600 °C]. 




of the carrier and the nature of interaction between the 
drug molecule play a critical role on the drug delivery 
efficacy
74
. Ampicillin has three distinct UV 
absorption peaks at 257, 262 and 268 nm respectively. 
In this study, we have investigated the adsorption and 
subsequent release profile of ampicillin drug molecule 
on the morphologically derived ZnO particles by 
spectrophotometric technique by monitoring the 
change in peak intensity at 268 nm. The experiment 
was performed in two stages. At first, ampicillin was 
loaded on ZnO-1 and ZnO-4 particles respectively, 
under identical conditions to distinguish the effect of 
morphological and microstructural changes for rod-
like and hollow-spherical particles on the drug 
loading. Conditions were optimized according to the 
described method to ascertain similar level of drug 
loading on both the particles. The loading for  
ZnO-1 and ZnO-4 were 6.3% and 5.9% by weight 
respectively obtained by the thermogravimetric 
analysis. (Supplementary Data, Fig S5). The drug 
release profiles of ZnO-1 and ZnO-4 are presented in 
Fig. S6 (Supplementary Data). It is evident from the 
data that drug release is consistent as the time 
progresses from 1 h to 24 h for both ZnO-1 and ZnO-4. 
The release profile shows greater delivery in the 
initial time scale which progressively becomes 
saturated with time. It is interesting to note that the 
release profile is higher for ZnO-1 compared to  
ZnO-4 for similar loading of the drug. The ratio of 
drug release of ZnO-1: ZnO-4 was 2.5, 1.5, 1.2 and 
1.1 times corresponding to 1, 2, 3 and 4 h 
respectively. The release of drug tends to saturate 
with increase in time and with 24 h exposure, the 
microstructural effect was not found to be significant. 
The result evidently shows that ZnO-4 can retain the 
drug molecule more compared to ZnO-1 and thus act 
as a better agent for sustained release of ampicillin 
drug. This observation can be explained on the basis 
of the relative size and surface area difference 
between ZnO-1 rods and ZnO-4 microspheres. It is 
known that with a decrease in size of particle, there is 
a consequent increase in the surface area to volume 
ratio. Wim et al.
74
 demonstrated that lowering the 
surface area for a given size, results in lowering of the 
leaching rate of the drug from the core of the 
microspheres compared to that of the rods. 
Additionally, the physical entrapment of drug 
molecules in the hollow spaces may aid in their 
sustained release profile. 
Conclusions 
In this work, we have demonstrated a one-step 
hydrothermal route to synthesize ZnO hollow 
microspheres using (+)-catechin as crystal habit 
modifier. The concentration of the crystal habit 
modifier played a critical role in tuning the 
morphology from rod-like to spherical shape, with 
small openings on the surface. The microspheres were 
formed by the aggregation of nanoparticulate ZnO. 
The synthesized microspherical particles showed 
improved photocatalytic and drug delivery properties 
which can be compared to conventional counterparts. 
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